This unique app helps users optimize their training routines by syncing with their hormonal cycles. Launched in 2021 by an athlete for other athletes, this app provides personalized recommendations based on over 450 scientific studies, supporting users through different hormonal stages, including 150+ types of birth control.
This app is already loved by users with clear product-market fit, it’s built on hard-to-replicate science, giving it a strong moat and making it a global leader in its niche. As well as that, it comes with a validated, recognized brand and an incredibly active email list—over 17k people with a 70%+ open rate over the last 180 days.
The strongest markets for this app are the USA (49.6%), UK (10%), and Brasil (9.6%). Over the past 12 months, Downloads grew to 39.8K, and Proceeds reached $168.6K, reflecting a 196.3% growth.
This app is monetized by in-app purchases, B2B API revenue and subscriptions with the majority of the subscriptions being annual. It had its best year of proceeds in 2024, demonstrating its significant growth potential.They are currently in talks with some major players on the B2B side about contracts around their API.
This app offers the opportunity for a buyer to capitalise on the investment that has gone into this across R&D.
Highlights:
Growth Potential:
Deal Assets:
The whole team except the CEO can stay on post transaction
The app owner is looking to sell, as they want to move on from the project.